Advertisement
Canada markets close in 3 hours 9 minutes
  • S&P/TSX

    22,039.42
    +167.46 (+0.77%)
     
  • S&P 500

    5,069.89
    +59.29 (+1.18%)
     
  • DOW

    38,497.56
    +257.58 (+0.67%)
     
  • CAD/USD

    0.7316
    +0.0015 (+0.21%)
     
  • CRUDE OIL

    83.04
    +1.14 (+1.39%)
     
  • Bitcoin CAD

    91,291.06
    +846.96 (+0.94%)
     
  • CMC Crypto 200

    1,434.03
    +19.27 (+1.36%)
     
  • GOLD FUTURES

    2,343.10
    -3.30 (-0.14%)
     
  • RUSSELL 2000

    2,002.43
    +34.96 (+1.78%)
     
  • 10-Yr Bond

    4.5840
    -0.0390 (-0.84%)
     
  • NASDAQ

    15,688.00
    +236.70 (+1.53%)
     
  • VOLATILITY

    16.28
    -0.66 (-3.90%)
     
  • FTSE

    8,044.81
    +20.94 (+0.26%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • CAD/EUR

    0.6836
    -0.0014 (-0.20%)
     

Where Will Ocugen Be in 1 Year?

Where Will Ocugen Be in 1 Year?

The past 18 months have been a roller coaster for Ocugen (NASDAQ: OCGN). Shares of the biotech company skyrocketed in early 2021 after it announced an agreement with India-based Bharat Biotech. The deal stipulated that Ocugen would hold the right to commercialize the Covaxin coronavirus vaccine, which was originally developed by Bharat Biotech, in the U.S. and Canada.